What is Bloom Burton’s Estimate for ABCL FY2025 Earnings?
AbCellera Biologics Inc. (NASDAQ:ABCL – Free Report) – Bloom Burton reduced their FY2025 EPS estimates for shares of AbCellera Biologics in a research note issued on Monday, March 3rd. Bloom Burton analyst D. Martin now expects that the company will earn ($0.73) per share for the year, down from their prior estimate of ($0.52). The […]
